Marimed (MRMD) Restructuring Costs (2022 - 2026)

Marimed (MRMD) has reported Restructuring Costs for 5 consecutive years, with $116000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Restructuring Costs fell 16.55% year-over-year to $116000.0 in Q2 2026; TTM through Jun 2026 was $520000.0, a 32.29% decrease from a year earlier, with the FY2025 full-year figure at $486000.0, down 48.9% from the prior year.
• Restructuring Costs was $116000.0 for Q2 2026 at Marimed, down from $169000.0 in the prior quarter.
• Over five years, Restructuring Costs peaked at $754000.0 in Q2 2022 and troughed at $32000.0 in Q3 2023.
• A 5-year average of $198705.9 and a median of $143000.0 in 2022 frame the typical range for Restructuring Costs.
• Across the five-year window, Restructuring Costs sank 77.62% in 2023 and surged 1059.38% in 2024, its largest moves.
• Over 5 years, Restructuring Costs stood at $64000.0 in 2022, then declined by 25.0% to $48000.0 in 2023, then soared by 204.17% to $146000.0 in 2024, then tumbled by 38.36% to $90000.0 in 2025, then rose by 28.89% to $116000.0 in 2026.
• The last three Restructuring Costs figures came in at $116000.0 (Q2 2026), $169000.0 (Q1 2026), and $90000.0 (Q4 2025), per Business Quant data.